Used primarily in research settings, this compound functions as a selective inhibitor of Janus kinase 2 (JAK2), making it a valuable tool for studying signaling pathways involved in hematological malignancies. It demonstrates activity against cell lines with JAK2 mutations, particularly those associated with myeloproliferative disorders, allowing scientists to explore targeted therapeutic strategies. Additionally, it has been investigated for its effects on cancer stem cells and its potential to suppress tumor growth in preclinical models. Due to its specificity, it is often employed to dissect JAK-STAT signaling mechanisms in cellular and molecular studies.